Cutting Edge Information
Blockbuster drugs are backed with big budgets
Published in Pharma Investments, Ventures and Law Weekly, February 12th, 2006
"Pharmaceutical Product Commercialization: phase III to Post-Launch Resource Allocation" examines the marketing investments of 16 brands, from blockbusters to niche drugs. The report findings highlight the importance of adequate funding prior to and just after launch. Of the three categories, blockbuster brands, which usually represent major investments for companies, received the most financial support during this critical period.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Acadia Pharmaceuticals, Inc.
Pharmaceutical company reports additional $10M equity investment by Sepracor - Adlyfe, Inc.
Protein detection technology developer secures $3.3M in series A round - Advanced BioPhotonics Inc.
Medical imaging company restructures and reduces board of directors - Advanced BioPhotonics, Inc.
Imaging company closes on second financing milestone - Akorn, Inc.
Ophthalmic drug developer retires series A preferred stock - Aksys, Ltd.
Dialysis systems developer reports $20M stock purchase agreement - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
